Benzylpenicillin
- Generic Name
- Benzylpenicillin
- Brand Names
- Bicillin, Bicillin L-A, Pfizerpen
- Drug Type
- Small Molecule
- Chemical Formula
- C16H18N2O4S
- CAS Number
- 61-33-6
- Unique Ingredient Identifier
- Q42T66VG0C
- Background
Benzylpenicillin (Penicillin G) is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms.
...
- Indication
For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.
- Associated Conditions
- Actinomycosis, Acute Rheumatic Fever, Anthrax, Bloodstream Infections (BSI), Clostridium Botulinum Toxin Adverse Reaction, Diphtheria, Empyema, Endocarditis, Endocarditis caused by Erysipelothrix infections, Fusospirochetosis, Gas Gangrene, Gonococcal infections, Gram-Negative Bacterial Infections, Haverhill fever, Listeria infection, Meningitis, Meningococcal Meningitis, Pasteurella infections, Pericarditis, Pneumonia, Syphilis, Tetanus, Rat bite fever
- Associated Therapies
- -
Pharmaceutical Plants Launched Under PLI Scheme to Reduce Import
Govt inaugurates two greenfield plants under PLI scheme to reduce pharma imports, focusing on penicillin G, 6-APA, and clavulanic acid production. These plants aim to cut import dependence by 50% for penicillin G and 6-APA, and by 40% for clavulanic acid, enhancing India's self-sufficiency in drug production.
Global Necrotizing Fasciitis Treatment Market Set to Reach USD 4.5 Billion by ...
The global necrotizing fasciitis treatment market is expected to grow from USD 2.9 billion in 2024 to USD 4.5 billion by the forecast period's end, driven by personalized therapies, targeted antimicrobial treatments, and advanced imaging technologies. Key players are innovating with novel antibiotics, biologics, and less invasive surgical methods, while strategic collaborations accelerate breakthroughs. Recent developments include GSK's acquisition of Elsie Biotechnologies and Merck's partnership with Mycenax Biotech.
Your skin tone impacts how well your medications work
Skin tone affects medication safety and efficacy; melanin binds with drugs, influencing pharmacokinetics and pharmacodynamics. Clinical trials lack diversity, often excluding underrepresented populations. Researchers call for inclusive drug testing using diverse 3D human skin models to ensure equitable drug safety and dosing.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath